Health Condition 1: A488- Other specified bacterial diseases
Conditions
Interventions
None listed
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: All melioidosis cases with or without comorbidities (diabetes, alcoholism, renal disease etc.). Individuals having no signs and symptoms of fever, pneumonia, abscess, lymphadenitis and no past history of hospitalization for last 3 months.
Exclusion criteria
Exclusion criteria: Pregnant women. Individuals with disease like arthritis, malignancy and on immunosuppressive therapy. The patients with above mentioned chronic diseases might have a negative impact that giving to a false positive result in seroprevalence study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study will provide information about the difference in the gut microbiota among localized versus disseminated infection.The changes in abundance of gut microbiota between melioidosis cases and seropositive individual. The influence of long-term antibiotic treatment on the abundance of gut microbiots in patients.Timepoint: 2020-2023. Gut microbiota analysis with Journal publication-2020-2021. | — |
Secondary
| Measure | Time frame |
|---|---|
| The differences in cytokine expression of disseminated versus localized melioidosis with prognosis and outcome of patients having comorbiditiesTimepoint: Cytokine analysis with journal publications - 2021-2023. | — |
Countries
India
Contacts
Public ContactSoumi Chowdhury
Kasturba Medical College
Outcome results
None listed